1. Expression of Epithelial–Mesenchymal Transition Markers in Epidermal Layer of Atopic Dermatitis
   Kazuyuki Kitazawa et al, 2024, Biological and Pharmaceutical Bulletin CrossRef
2. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
   Shixin Zhao et al, 2022, Frontiers in Surgery CrossRef
3. The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
   Jędrzej Borowczak et al, 2022, Biomedicines CrossRef
4. Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression
   Yixin Ding et al, 2023, International Journal of General Medicine CrossRef
5. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle
   Xiaolong Tang et al, 2023, Disease Markers CrossRef
6. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche
   Hajar Rajayi et al, 2019, International Reviews of Immunology CrossRef
7. Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment
   Simon Schreiber et al, 2021, Frontiers in Immunology CrossRef
8. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis
   ZhaoHui Xu et al, 2022, International Journal of General Medicine CrossRef
9. Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers
   Ikenna Uchendu et al, 2023, Current Pharmaceutical Design CrossRef
10. Transcription Factors in Cancer
    Rawiah A. Alsiary et al, 2023, Molecular Targets and Cancer Therapeutics (Part 1) CrossRef
11. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling
    Hao Liu et al, 2021, Journal of Immunology Research CrossRef
12. Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
    Yan Li et al, 2021, Aging CrossRef
13. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma
    Junsheng Zhao et al, 2024, Frontiers in Immunology CrossRef
14. Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining
    Yan Lin et al, 2019, Aging CrossRef
15. E2F1-induced PROX1-AS1 contributes to cell growth by regulating miR-424-5p/CPEB2 pathway in endometrial carcinoma
    Yiwan Chen et al, 2022, Molecular & Cellular Toxicology CrossRef
16. Astragalus membranaceus (Fisch.) Bunge repairs intestinal mucosal injury induced by LPS in mice
    Yizhe Cui et al, 2018, BMC Complementary and Alternative Medicine CrossRef
17. An Update on the Potential Roles of E2F Family Members in Colorectal Cancer
    ZhaoHui Xu et al, 2021, Cancer Management and Research CrossRef
18. Comprehensive analysis of the prognostic and immunotherapeutic implications of STAT family members in human colorectal cancer
    Dingchang Li et al, 2022, Frontiers in Genetics CrossRef
19. Differential Gene Expression and Weighted Correlation Network Dynamics in High-Throughput Datasets of Prostate Cancer
    Taj Mohammad et al, 2022, Frontiers in Oncology CrossRef
20. The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular Carcinoma
    Chunlei Li et al, 2022, Journal of Oncology CrossRef
21. E2F1 modulates RCCD1 expression to participate in the initiation and progression of EMT in colorectal cancer
    Shanshan Han et al, 2024, Pathology - Research and Practice CrossRef